An Open-Label, Staggered Rising Dose Cohort Study Assessing the Pharmacokinetics, Safety, and Tolerance of BI-RG-587 in Combination With Zidovudine in Patients With HIV Infection (CD4+ Cell Count < 400/mm3)
PHASE1CompletedINTERVENTIONAL
Enrollment
30
Participants
Timeline
Start Date
Not specified
Conditions
HIV Infections
Interventions
DRUG
Nevirapine
DRUG
Zidovudine
Trial Locations (3)
35233
Cooper Green Hosp, Birmingham
921036325
Univ of California / San Diego Treatment Ctr, San Diego
NCT00000649 - An Open-Label, Staggered Rising Dose Cohort Study Assessing the Pharmacokinetics, Safety, and Tolerance of BI-RG-587 in Combination With Zidovudine in Patients With HIV Infection (CD4+ Cell Count < 400/mm3) | Biotech Hunter | Biotech Hunter